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Abstract
Background:  Array comparative genomic hybridization (aCGH) is a popular technique for
detection of genomic copy number imbalances. These play a critical role in the onset of various
types of cancer. In the analysis of aCGH data, normalization is deemed a critical pre-processing
step. In general, aCGH normalization approaches are similar to those used for gene expression
data, albeit both data-types differ inherently. A particular problem with aCGH data is that
imbalanced copy numbers lead to improper normalization using conventional methods.
Results: In this study we present a novel method, called CGHnormaliter, which addresses this
issue by means of an iterative normalization procedure. First, provisory balanced copy numbers are
identified and subsequently used for normalization. These two steps are then iterated to refine the
normalization. We tested our method on three well-studied tumor-related aCGH datasets with
experimentally confirmed copy numbers. Results were compared to a conventional normalization
approach and two more recent state-of-the-art aCGH normalization strategies. Our findings show
that, compared to these three methods, CGHnormaliter yields a higher specificity and precision in
terms of identifying the 'true' copy numbers.
Conclusion: We demonstrate that the normalization of aCGH data can be significantly enhanced
using an iterative procedure that effectively eliminates the effect of imbalanced copy numbers. This
also leads to a more reliable assessment of aberrations. An R-package containing the
implementation of CGHnormaliter is available at http://www.ibi.vu.nl/programs/
cghnormaliterwww.
Background
Array comparative genomic hybridization (aCGH) is an
experimental approach used to scan an entire genome for
copy number changes at a high resolution [1]. These
changes occur particularly in oncogenes where mutations
can lead to either gains or losses of genetic material. Con-
sequently, aCGH is a commonly used technique to iden-
tify aberrations leading to tumors [2-4]. In aCGH
experiments, test and reference DNA samples are labeled
with distinct dyes and hybridized to cloned DNA frag-
ments of which the exact genomic location is known. For
each DNA region the two-dye intensities are measured by
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fluorescence from which the corresponding log2 intensity
ratios (M) are calculated. A ratio value close to zero indi-
cates a normal copy number (e.g. two in diploids) while a
value above or below zero indicates a gain or a loss,
respectively. Nonetheless, the proper assessment of copy
numbers is not a trivial task and several computational
algorithms have been developed for normalization,
smoothing, segmentation and calling [5-9]. The normali-
zation procedure, the first stage of the aCGH analysis,
aims to minimize the effect of the technical bias (e.g. dye
bias) in log2 intensity ratios. Usually aCGH normalization
is based upon methods applied to gene expression data,
i.e. global-median and intensity-based LOWESS normali-
zation [10]. In global-median normalization a median M
value is determined and subtracted from all M values. By
doing so, the M values become centered around a median
value of zero. Intensity-based LOWESS normalization
instead fits a smooth regression line through all M value
points. Normalization is achieved by subtracting from
each M value its corresponding regression value. These
conventional techniques however are in the majority of
cases not applicable to aCGH data. This is due to the fact
that relevant biological variation is often erroneously
treated as technical bias and removed. For instance,
probes corresponding to gains (which on average have
higher intensities) are generally 'over-normalized' making
a proper assessment of gains more difficult. A recently
developed method, called popLowess, attempts to tackle
this problem by separating the aberrations from the nor-
mals through k-means (k = 3) clustering [11]. In this man-
ner the normalization is only based on the population of
normal probe values. The problem however is that 'call-
ing' through a clustering method is rather course-grained
while several more refined methods are available [9,12-
14]. Another recent normalization and centralization
method that seeks to overcome over-normalization was
proposed by Chen et al. [5]. In their algorithm normaliza-
tion is performed by regressing the highest ridgeline of a
2-dimensional intensity distribution which is assumed to
correspond to normal probes. Subsequently, the most
occurring probe intensity (i.e. the highest peak in the
intensity distribution) is used for centralization.
In this study we present a new method, called CGHnor-
maliter, which offers a more sophisticated normalization
of aCGH data. First we perform segmentation after which
we use a custom calling method to accurately assess nor-
mals, gains and losses. In the 3rd step we fit a LOWESS
regression curve through the normals only and use that to
normalize the entire population of probes. Subsequently
new segments are determined. In step 5 we re-run the call-
ing method which can reach an even higher calling accu-
racy based on the normalized data. Steps 3–5 are then
iteratively repeated until convergence or a user-specified
maximum number of iterations is reached. An overview is
given in Figure 1. We applied our method to three tumor-
related aCGH datasets for which the 'true' copy number
changes were determined using spectral karyotyping
(SKY), G-banding and/or fluorescence in situ hybridiza-
tion (FISH). To the best of our knowledge such an
extended and high quality benchmark is used here for the
first time. The performance was compared to three other
normalization strategies: a conventional global-median
approach, popLowess and the method by Chen et al. In
the majority of cases CGHnormaliter showed a higher
performance in terms of sensitivity, specificity and preci-
sion. An implementation of CGHnormaliter is available
as an R-package and can be downloaded from http://
www.ibi.vu.nl/programs/cghnormaliterwww.
Results and Discussion
Evaluation criteria
In this work we compared the performance of three previ-
ously proposed normalization strategies (global-median,
popLowess and Chen et al.) to our novel CGHnormaliter
method. Our benchmark consists of three aCGH datasets
with experimentally verified imbalanced aberrations.
Normalization methods were applied to each benchmark
set, followed by segmentation and calling using DNAcopy
[15] and CGHcall [14], respectively. Subsequently the
calling performance was evaluated in terms of sensitivity,
Overview of the CGHnormaliter method Figure 1
Overview of the CGHnormaliter method. First break-
points and segments are detected (step 1) and initial calling is 
performed to distinguish normals from gains and losses (step 
2). Subsequently, a 'local-LOWESS normalization' procedure 
is followed which uses only the normals to calculate the 
LOWESS regression curve (step 3). The following step con-
sists of break-point detection and segmentation (step 4) after 
which new calls are established (step 5). If the latter calling 
differs with respect to the previous calling, the procedure is 
repeated from step 3.
ΟΡΦΔΟ /2:(66 
ΘΡΥΠΔΟΛ]ΔΩΛΡΘ
ΛΘΛΩΛΔΟ ΦΔΟΟΛΘϑ
ΛΩΗΥΔΩΛΡΘ
ςΩΗΣ  
ςΩΗΣ  
ςΩΗΣ  
ςΩΗΣ  
ΦΔΟΟΛΘϑ ςΩΗΣ  
ςΗϑΠΗΘΩΔΩΛΡΘ
ςΗϑΠΗΘΩΔΩΛΡΘBMC Genomics 2009, 10:401 http://www.biomedcentral.com/1471-2164/10/401
Page 3 of 7
(page number not for citation purposes)
specificity and precision. Sensitivity is calculated as fol-
lows:
where TP indicates the number of true positives and FN
the number of false negatives. Specificity is defined as:
where TN indicates the number of true negatives and FP
the number of false positives. Finally, precision is defined
as:
Our interpretation of TP, TN, FP and FN is explained in
Table 1. As a standard procedure, we have taken the gains
and losses as positives since they are indicative for disease.
Performance on the acute lymphoblastic leukemia (ALL) 
dataset
In Figure 2A the average performance of all methods on
the ALL dataset is displayed. From this figure it is clear that
global-median normalization is outperformed by all
other methods. popLowess and CGHnormaliter yield
comparable results for all evaluation criteria (0.81 on
average). Chen et al. performs slightly worse (0.77 on
average) whereas global-median scores are considerably
lower for sensitivity (0.57) and precision (0.62). We also
investigated the underlying causes of the inferior perform-
ance of global-median normalization. As expected we
found, particularly in cases where a large number of
imbalanced aberrations occur, that global-median does
not properly yield a normal copy number. In such cases,
'over-normalization' of the data occurs, leading to exces-
sively shifted spot intensity ratios. A salient example is
given in Figure 3, where calling results of a tumor sample
are shown after global-median and CGHnormaliter nor-
malization. In this sample gains were experimentally ver-
ified in 14 out of 24 chromosomes. In the global-median
approach the median is rather high, leading to an overes-
timation of the number of losses and underestimation of
the number of gains. In fact, only 11 out of 14 gains were
(partially) recognized. CGHnormaliter (and also
popLowess) attempts to correct for this problem and is
able to properly identify 13 gains. Finally, in Table 2 we
compare the effect of each normalization method on the
resulting M values. It is clear that alternative strategies lead
to considerably different shifts in the M values, whereas
the final calling results are more similar (see Figure 2A).
Performance on the gastrointestinal stromal tumor (GIST) 
dataset
Results on the GIST dataset are summarized in Figure 2B.
CGHnormaliter performs best on all evaluation criteria
(sensitivity = 0.72, specificity = 0.94 and precision = 0.45).
The method by Chen et al. is second best and scores 4 per-
centage points lower on average. Furthermore global-
median and popLowess show similar performances but
on average 10 percentage points lower than CGHnormal-
iter. In Figure 4 we further elucidate the differences in per-
formance between popLowess and CGHnormaliter. For
this tumor sample, losses were experimentally verified in
2 out of 24 chromosomes. Although both methods are
able to identify a considerable part of them, CGHnormal-
iter scores considerably better in specificity and precision
(plus 8 and 19 percentage points, respectively). This can
be explained by the observation that popLowess identifies
only a fraction of the 'true' normals as normals during its
clustering step, so only normals with high M values are
used for normalization. As a consequence the LOWESS
regression line becomes too high and the normalized M
values too low, leading to an overestimation of the
number of losses. In CGHnormaliter the normals are bet-
ter recognized, yielding a more accurate centralization of
the  M  values. The difference between normalization
methods in terms of the resulting M values is substantial
though less pronounced relative to the ALL dataset
(Table 2).
Performance on the human melanoma cell line dataset
Results on the melanoma dataset are shown in Figure 2C.
CGHnormaliter performs best on specificity (0.90) and
precision (0.81), while global-median normalization is
sensitivity
TP
TP FN
=
+
specificity
TN
TN FP
=
+
precision
TP
TP FP
=
+
Table 1: Definition of true positives (TP), false positives (FP), 
true negatives (TN) and false negatives (FN).
prediction (call)
gain/loss normal
gold gain/loss TP FN
standard normal FP TN
Table 2: Effect of different normalization strategies on the M 
values. 
ALL GIST Melanoma
global-median -0.098 0.344 -0.751
popLowess -0.239 0.348 -0.760
Chen et al. -0.228 0.315 -0.508
CGHnormaliter -0.204 0.304 -0.439
Numbers represent the mean shifts between the original and 
normalized M values.BMC Genomics 2009, 10:401 http://www.biomedcentral.com/1471-2164/10/401
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slightly more sensitive than CGHnormaliter (0.77 versus
0.76). popLowess and Chen et al. perform several percent-
age points worse compared with CGHnormaliter on all
evaluation criteria. It should be stressed however that the
somewhat higher sensitivity yielded by global-median can
be attributed to a strikingly good performance on a single
sample being the human melanoma cell line WM983. In
this case centralization of aCGH data is rather compli-
cated since more than half of the WM983 genome is aber-
rated. Overall the results are in line with the previous two
datasets where CGHnormaliter outperforms the competi-
tors tested.
Perspectives/limitations
The work we present here is based on a thorough compar-
ison of a number of aCGH normalization methods
involving several testsets. Further investigation should not
only comprise larger datasets containing significantly
more samples, but should also involve additional high-
density platforms, such as Nimblegen. It goes without say-
ing that future development of aCGH data analysis meth-
ods will be largely dependent on the size and quality of
benchmark sets.
As a next step in the future development of our method
we aim to extend the protocol by allowing single-channel
data, or dual-channel data for which intensity values are
not available. This could be achieved by implementing an
iterative local-median strategy as an alternative to the
local-LOWESS strategy currently used. In this way the gen-
eral applicability of CGHnormaliter would be enhanced.
Finally, it should be stressed that a major pitfall of all
methods occurs in cases that display many imbalanced
copy number alterations. In samples where the number of
gains or losses exceeds the number of normals, the data
will be centralized around these gains or losses, leading to
an incorrect normalization. Another drawback appears in
sets where the ploidy of the reference and test sample dif-
fers, usually as a result of hypoploidy of the test sample.
For instance, if the ploidy of reference and test are m and
n (where m ≠ n), respectively, the centralization should be
around   instead of zero as employed by current
methods. The integration of prior knowledge concerning
the ploidy, number and nature of aberrations is likely to
be key in alleviating these complications.
Conclusion
We introduce a new strategy, called CGHnormaliter, for
improved normalization of aCGH data displaying imbal-
anced aberrations. Our method was tested on three well-
studied test sets (ALL, GIST and Melanoma) which are
unique considering the large number of extensively vali-
dated samples and the occurrence of many imbalanced
aberrations. The performance was compared with a con-
ventional global-median approach and the recently pub-
lished tools popLowess [11] and that by Chen et al. [5].
We conclude that on average CGHnormaliter outper-
forms the three other methods in terms of specificity and
precision, while its overall sensitivity is comparable to
that obtained by popLowess and Chen et al.. The global-
median approach scores considerably lower on almost all
data samples, mainly due to over-normalization: the pres-
ence of many imbalanced aberrations leads to an
improper centralization of the intensity ratios. Further-
more, in a number of cases popLowess and Chen et al.
achieve similar results as CGHnormaliter since all meth-
ods only use the normals for normalization. However, in
some examples the identification of the normals is not
trivial. In such cases the iterative refinement steps of CGH-
normaliter yield better results than the single clustering
step of popLowess or the 'highest ridgeline regression'
strategy by Chen et al.. It would be interesting to further
investigate these findings and combine the iterative proto-
col with alternative normalization approaches. Nonethe-
less this research emphasizes the importance of
normalization based on properly defined normals and
log2
m
n ()
Comparison of method performance in terms of sensitivity,  specificity and precision Figure 2
Comparison of method performance in terms of sen-
sitivity, specificity and precision. Overall results for (A) 
the acute lymphoblastic leukemia (ALL), (B) the gastrointes-
tinal stromal tumor (GIST), and (C) the human melanoma 
cell lines dataset are given.
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Example of the effects over-normalization using global-median normalization Figure 3
Example of the effects over-normalization using global-median normalization. Calling results on an ALL tumor 
sample (sample 4) after (A) global-median and (B) CGHnormaliter normalization are shown. In these figures normalized log2 
intensity ratios and segments are represented by dots and blue horizontal lines, respectively. Aberration probabilities are indi-
cated by the length of the green downward (gain) and red upward (loss) bars. Note that segments are designated gain or loss if 
their probabilities exceed 0.5. G-banding and FISH analyses revealed gains in 14 chromosomes (4, 5, 6, 7, 8, 10, 11, 12, 14, 17, 
18, 21, 22, 23(X)) most of which are confirmed using CGHnormaliter. Over-normalization caused by global-median normaliza-
tion instead leads to many incorrect calls.
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Example where CGHnormaliter achieves better results than popLowess due to more sophisticated clustering of the intensity  ratios Figure 4
Example where CGHnormaliter achieves better results than popLowess due to more sophisticated clustering 
of the intensity ratios. Calling results on a GIST tumor sample (sample 57) after (A) popLowess and (B) CGHnormaliter 
normalization are shown. FISH analyses revealed losses in 2 chromosomes (14 and 15). All losses are identified largely by both 
methods but CGHnormaliter scores better in specificity and precision. The figure format is explained under Figure 3.
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shows the added value of iteration for proper assessment
of such normals.
Methods
CGHnormaliter algorithm
CGHnormaliter is a normalization method tailored to
aCGH data. Its novelty resides both in the fact that nor-
malization is guided by a more sophisticated calling tech-
nique and that further refinement is attained through a
new iteration procedure. The strategy can be summarized
as follows. Initially the log2 intensity ratios are segmented
using DNAcopy [15]. The segmented data are then given
as input to a recently developed calling tool named CGH-
call [14] to discriminate the normals from gains and
losses. The assumption here is that the temporary exclu-
sion of aberrations allows for a more appropriate calcula-
tion of the LOWESS regression curve. As a result, after
normalization, the log2 intensity ratios of the normals will
generally be closer to zero and better reflect the biological
reality. We coin this normalization strategy 'local-LOW-
ESS' because only a subset of the intensity ratios is consid-
ered in the LOWESS regression. The thus normalized data
are then segmented again and called. It is likely that the
new calls will be more accurate than the previous ones
because these are now based on normalized data. In turn,
further iterative normalization might benefit from these
improved calls. To control iteration, CGHnormaliter
needs to establish whether the normalization results have
been significantly changed or not. Iterations are termi-
nated if each of the samples shows a mean difference rel-
ative to its value in the preceding iteration below α
(default α = 0.01). Alternatively, the user can set a maxi-
mum number of iterations.
We also included a feature to prevent 'wandering' of the
median during the iterative steps of CGHnormaliter. This
might occur if a large number of gains or losses are
present. In this situation it is likely that the calling algo-
rithm will select many of these as normals. As a conse-
quence an undesired upward (or downward) bias of the
baseline can be observed, resulting in a biologically unre-
alistic number of losses (or gains), which will typically get
worse during subsequent iterations. To prevent this we
denote the largest copy number population as normals
and adjust all calls accordingly.
Other normalization methods
To test the global-median normalization strategy, we used
the implementation in the R-package CGHcall version
1.2.0 [14]. In this routine standard global-median nor-
malization is combined with a smoothing step [15] to
remove outliers. For popLowess we used the standalone
version 1.0.1 (with a lower limit of 1 for the 'smoothing
size' to guarantee normalization of all chromosomes). For
the method by Chen et al. we used the MatLab implemen-
tation provided by the authors. All programs were run
using default parameter settings.
Data
In this study we used three tumor-related benchmark
aCGH datasets for method evaluation. These were
selected since they contain a considerable amount of sam-
ples with imbalanced copy numbers which are cytogenet-
ically verified using SKY, G-banding and/or FISH. The first
dataset comprises 8 acute lymphoblastic leukemia (ALL)
tissue samples which were analyzed using 32 K BAC arrays
([16], see Additional file 1). The second dataset consists of
17 gastrointestinal stromal tumors (GIST). These were
analyzed using 3 K BAC and PAC arrays where only spots
with signal intensities of at least two times the back-
ground intensities were included ([17], GSE5336, see
Additional file 2). The third dataset includes samples from
4 human melanoma cell lines, which were analyzed using
Agilent 44 K oligonucleotide-based CGH arrays ([18],
GSE7822, see Additional file 3).
Availability and requirements
Project name: CGHnormaliter R package
Project home page: http://www.ibi.vu.nl/programs/cgh
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